Drug Trial Radar · NCT05434897
A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar
Last checked: Nov 19, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jul 8, 2022
Primary completion
Jul 18, 2023
Study completion Jul 18, 2023
Sponsor
- Lead sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blind, placebo self-controlled phase I/II clinical study to evaluate the safety, tolerability and preventive efficacy of different doses of AK3280 cream (AK3287 ) after cicatrectomy in Patients with Hypertrophic Scar in China.
Conditions
- Hypertrophic Scar
Interventions
AK3280 CreamDrug
Active Substance: AK3280, Pharmaceutical Form:Cream, Route of Administration: External use
Placebo creamDrug
Active Substance: Placebo, Pharmaceutical Form: Cream, Route of Administration: External use
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of adverse events(AE)/ serious adverse events (SAEs)Time frame: Up to 14 weeks
- Number of participants with abnormal Skin ExaminationTime frame: Up to 14 weeks
- Number of participants with abnormal vital signsTime frame: Up to 14 weeks
- Number of participants with abnormal Physical examination findingsTime frame: Up to 14 weeks
- Number of participants with abnormal 12-lead ECG readingsTime frame: Up to 14 weeks
- Number of participants with abnormal laboratory test resultsTime frame: Up to 14 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai Ninth People's Hospital,Shanghal JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.